Notice Concerning the Change of Executive Officers as of April 1, 2024
TOKYO, JAPAN – December 14, 2023 – Terumo Corporation (TSE: 4543) hereby announces that
it has resolved at the Board of Directors held on December 14, 2023 to change the Executive Officers
as described below.
1. Change of Representative Director (As of April 1, 2024)
| Name |
New Position |
Current Position |
| Shinjiro Sato |
Director and Corporate Advisor |
President and CEO |
| Toshiaki Takagi |
Chairman of the Board (continuing
the current position) |
Chairman of the Board |
2. Election of President and CEO (As of April 1, 2024)
| Name |
New Position |
Current Position |
| Hikaru Samejima |
President and CEO |
Group Senior Managing Executive
Officer
President, Medical Care Solutions
Company |
*Hikaru Samejima, is planned to be elected as a candidate of director for the next term at the Board
of Directors to be held on February 7, 2024. Subsequently, he is planned to be elected as a
Representative Director after getting approval to be a Director at the Annual General Meeting of
Shareholders to be held on June 26, 2024.
3. Reason for Change
Due to the completion of Shinjiro Sato’s term of office
4. Scheduled Date of Assuming Office
April 1, 2024
5. About the Newly Appointed President and CEO
Name : Hikaru Samejima
Date of Birth : May 27, 1964
Education : B.A.Economics, Keio University (Graduated: March 1988)
Fuqua School of Business, Duke University (MBA) (May 1995)
Career Summary:
| April 1988 |
Joined Toa Nenryo Kogyo Corporation (now ENEOS Corporation)
|
| February 2001 |
Joined Citi Bank N.A
|
| January 2002 |
Joined the Company, Corporate Planning Department
|
| July 2006 |
Vice President, North America Business, Cardiac and Vascular Group
|
| June 2007 |
President, Terumo Interventional Systems (Global), Cardiac and Vascular
Group
|
| April 2014 |
Executive Officer
Division President, Interventional Systems Division, Cardiac & Vascular
Company
|
| April 2016 |
Senior Executive Officer
Division President, Interventional Systems Division, Cardiac & Vascular
Company
|
| April 2017 |
Senior Executive Officer President, Cardiac and Vascular Company |
| April 2018 |
Managing Executive Officer President, Cardiac and Vascular Company |
| April 2020 |
Managing Executive Officer President, General Hospital Company
|
| April 2022 |
Group Senior Managing Executive Officer
President, Medical Care Solutions Company (current) |
Number of Shares of the Company Held: 19,664dream
